A detailed history of Xtx Topco LTD transactions in Vaxart, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 136,466 shares of VXRT stock, worth $80,514. This represents 0.01% of its overall portfolio holdings.

Number of Shares
136,466
Previous 14,079 869.29%
Holding current value
$80,514
Previous $9,000 1177.78%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.58 - $0.99 $70,984 - $121,163
122,387 Added 869.29%
136,466 $115,000
Q2 2024

Aug 12, 2024

BUY
$0.53 - $1.3 $7,461 - $18,302
14,079 New
14,079 $9,000
Q4 2023

Feb 13, 2024

BUY
$0.57 - $0.85 $7,560 - $11,274
13,264 Added 93.57%
27,439 $15,000
Q3 2023

Nov 13, 2023

SELL
$0.69 - $0.85 $220,561 - $271,705
-319,654 Reduced 95.75%
14,175 $10,000
Q2 2023

Aug 14, 2023

BUY
$0.6 - $1.41 $200,297 - $470,698
333,829 New
333,829 $243,000
Q2 2022

Aug 15, 2022

BUY
$2.7 - $5.28 $32,805 - $64,152
12,150 New
12,150 $43,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $74.6M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.